We are live on ! Find out more
ARMP icon

Armata Pharmaceuticals
ARMP

19 hedge funds and large institutions have $2.6M invested in Armata Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

0.03% less ownership

Funds ownership: 4.69% → 4.66% (-0.03%)

7% less capital invested

Capital invested by funds: $2.79M → $2.6M (-$190K)

10% less funds holding

Funds holding: 21 → 19 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
19
Holders Change
-2
Holders Change %
-9.52%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
5
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$16.8K
2
UBS Group
UBS Group
Switzerland
+$11K
3
TRCT
Tower Research Capital (TRC)
New York
+$7.64K
4
SSB
Sandy Spring Bank
Maryland
+$953
5
Osaic Holdings
Osaic Holdings
Arizona
+$581

Top Sellers

Rank Fund Capital Flow
1
WS
Wedbush Securities
California
-$32K
2
BlackRock
BlackRock
New York
-$15.8K
3
GWM
Geneos Wealth Management
Colorado
-$1K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$181
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
1
Bank of America
North Carolina
$1.89M – – –
Renaissance Technologies
2
Renaissance Technologies
New York
$295K +$16.8K +5,298 +6%
Edgewood Management
3
Edgewood Management
Connecticut
$119K – – –
BlackRock
4
BlackRock
New York
$107K -$15.8K -4,970 -12%
Stifel Financial
5
Stifel Financial
Missouri
$59K – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$45K – – –
SWM
7
SeaCrest Wealth Management
New York
$38K – – –
TRCT
8
Tower Research Capital (TRC)
New York
$14K +$7.64K +2,404 +106%
UBS Group
9
UBS Group
Switzerland
$10K +$11K +3,470 +347,000%
Bank of Montreal
10
Bank of Montreal
Ontario, Canada
$9K – – –
Morgan Stanley
11
Morgan Stanley
New York
$6K – – –
SSB
12
Sandy Spring Bank
Maryland
$3K +$953 +300 +43%
Northwestern Mutual Wealth Management
13
Northwestern Mutual Wealth Management
Wisconsin
$2K – – –
TWA
14
TCI Wealth Advisors
Arizona
$1K – – –
Osaic Holdings
15
Osaic Holdings
Arizona
$1K +$581 +183 +61%
WS
16
Wedbush Securities
California
– -$32K -10,103 Closed
GWM
17
Geneos Wealth Management
Colorado
– -$1K -449 Closed
Royal Bank of Canada
18
Royal Bank of Canada
Ontario, Canada
– -$181 -57 -52%
SIAG
19
Safeguard Investment Advisory Group
California
– +$6 +2 New

ARMP Hedge Fund Activity: Q4 2020 in Review

19 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Armata Pharmaceuticals (ARMP) for Q4 2020, worth a combined $2.6M — down 6.8% from $2.79M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of ARMP and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 5 added.

The largest buyer was Renaissance Technologies, adding an estimated $16.8K. The largest seller was Wedbush Securities, exiting entirely with an estimated $32K sold.

  • 19 institutional investors held Armata Pharmaceuticals (ARMP) as of Q4 2020, down from 21 in Q3 2020.
  • Funds reported $2.6M of Armata Pharmaceuticals stock for Q4 2020, down 6.8% quarter-over-quarter.
  • 1 fund opened new Armata Pharmaceuticals positions in Q4 2020 and 3 closed out, a net change of -2 holders.
  • The largest Armata Pharmaceuticals buyer in Q4 2020 was Renaissance Technologies, an estimated $16.8K added.
  • The largest Armata Pharmaceuticals seller in Q4 2020 was Wedbush Securities, an estimated $32K sold.

Based on aggregated 13F filings for Q4 2020.